Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma

被引：1

作者：

Shao, Weilin ^{[1
]}

Feng, Yan ^{[1
]}

Huang, Jin ^{[1
]}

Li, Tingyu ^{[3
]}

Gao, Shengguai ^{[3
]}

Yang, Yihao ^{[1
]}

Li, Dongqi ^{[1
]}

Yang, Zuozhang ^{[1
]}

Yao, Zhihong ^{[1
,2
]}

机构：

[1] Kunming Med Univ, Yunnan Canc Hosp, Bone & Soft Tissue Tumours Res Ctr Yunnan Prov, Yunnan Canc Ctr,Affiliated Hosp 3,Dept Orthopaed, 519 Kunzhou Rd, Kunming 650118, Yunnan, Peoples R China

[2] Kunming Med Univ, Yunnan Canc Hosp, Yunnan Canc Ctr, Affiliated Hosp 3,Dept Canc,Res Inst, 519 Kunzhou Rd, Kunming 650118, Yunnan, Peoples R China

[3] Kunming Med Univ, Clin Oncol Inst, Kunming 650500, Yunnan, Peoples R China

来源：

OPEN LIFE SCIENCES | 2024年 / 19卷 / 01期

基金：

美国国家科学基金会;

关键词：

osteosarcoma; PI3K/AKT/mTOR; ncRNAs; biomarkers; therapeutic targets; PROMOTES CELL-PROLIFERATION; SIGNALING PATHWAY; NONCODING RNA; CISPLATIN RESISTANCE; DOWN-REGULATION; TUMOR PROGRESSION; CIRCULAR RNAS; UP-REGULATION; GROWTH; INVASION;

D O I：

10.1515/biol-2022-0936

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents, and is characterized by high heterogeneity, high malignancy, easy metastasis, and poor prognosis. Recurrence, metastasis, and multidrug resistance are the main problems that limit the therapeutic effect and prognosis of OS. PI3K/AKT/mTOR signaling pathway is often abnormally activated in OS tissues and cells, which promotes the rapid development, metastasis, and drug sensitivity of OS. Emerging evidence has revealed new insights into tumorigenesis through the interaction between the PI3K/AKT/mTOR pathway and non-coding RNAs (ncRNAs). Therefore, we reviewed the interactions between the PI3K/AKT/mTOR pathway and ncRNAs and their implication in OS. These interactions have the potential to serve as cancer biomarkers and therapeutic targets in clinical applications.

引用

页数：14

共 50 条

[31] Piceatannol Suppresses the Proliferation and Induced Apoptosis of Osteosarcoma Cells Through PI3K/AKT/mTOR Pathway
Wang, Bin
Li, Jingyu
CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 2631 - 2640
[32] Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway
Hu, Binwu
Lv, Xiao
Gao, Feng
Chen, Songfeng
Wang, Shangyu
Qing, Xiangcheng
Liu, Jianxiang
Wang, Baichuan
Shao, Zengwu
ONCOTARGETS AND THERAPY, 2017, 10 : 4379 - 4391
[33] Chitosan oligosaccharide suppresses osteosarcoma malignancy by inhibiting CEMIP via the PI3K/AKT/mTOR pathway
IlJin Sim
WonGyom Choe
JinJu Ri
Hang Su
Safwat Adel Abdo Moqbel
WeiQi Yan
Medical Oncology, 40
[34] Anti-tumor efficacy of phellamurin in osteosarcoma cells: Involvement of the PI3K/AKT/mTOR pathway
Zhang, Hongzhi
Jiang, Huijuan
Zhang, Huixiang
Liu, Juncai
Hu, Xigang
Chen, Lei
EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 858
[35] Chitosan oligosaccharide suppresses osteosarcoma malignancy by inhibiting CEMIP via the PI3K/AKT/mTOR pathway
Sim, IlJin
Choe, WonGyom
Ri, Jinju
Su, Hang
Moqbel, Safwat Adel Abdo
Yan, WeiQi
MEDICAL ONCOLOGY, 2023, 40 (10)
[36] PI3K/Akt signaling in osteosarcoma
Zhang, Jian
Yu, Xiao-Hua
Yan, Yi-Guo
Wang, Cheng
Wang, Wen-Jun
CLINICA CHIMICA ACTA, 2015, 444 : 182 - 192
[37] Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
Li, Huayi
Prever, Lorenzo
Hirsch, Emilio
Gulluni, Federico
CANCERS, 2021, 13 (14)
[38] PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
Li, Xiaoman
Wu, Changjing
Chen, Nianci
Gu, Huadi
Yen, Allen
Cao, Liu
Wang, Enhua
Wang, Liang
ONCOTARGET, 2016, 7 (22) : 33440 - 33450
[39] The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
Slomovitz, Brian M.
Coleman, Robert L.
CLINICAL CANCER RESEARCH, 2012, 18 (21) : 5856 - 5864
[40] Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy
Cidado, Justin
Park, Ben Ho
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2012, 17 (3-4) : 205 - 216

← 1 2 3 4 5 →